HD-OPM Archive
Hashtags

#il6

15 posts

Pelacarsen (Lp(a)HORIZON) and ziltivekimab (ZEUS) cut their targets but not heart events

Nov 13, 2026 · Louis Nervegna ♥ 3 · 💬 1 Lp(a)

Shared summary of two NEJM trials. Pelacarsen lowered Lp(a) sharply but event rates were 12.3% vs 12.1% on placebo, and ziltivekimab cut CRP and IL-6 but events were 17.6% vs 17.7%. The post notes prior biomarker failures (torcetrapib, dalcetrapib), and that both trials enrolled people with existing disease and so do not prove Lp(a) or inflammation are not causal.

Yale: taurine loss triggers NLRP3 inflammasome; raising taurine eased inflammaging in mice

Nov 06, 2026 · Louis Nervegna ♥ 7 Inflammation & CRP

Louis shares a summary of a Yale Cell study showing macrophages release up to 80% of their taurine after inflammatory triggers, which helps activate the NLRP3 inflammasome. Restoring taurine suppressed NLRP3 activation, and raising taurine in older mice improved grip strength, coordination, some glucose measures and inflammatory markers. It is preclinical research.

Inflammaging may begin around age 26 in men and 35 in women, ATTICA analysis finds

Nov 09, 2026 · Louis Nervegna ♥ 4 Inflammation & CRP

Louis shares a summary of an ATTICA analysis of 1,825 Greek adults showing a combined IL-6, TNF-alpha and fibrinogen immune activation score crosses into the activated range by about age 26 in men and 35 in women. IL-6 and fibrinogen rose steadily with age while CRP barely changed. Earlier studies link these markers to heart disease, diabetes, dementia and death.